– USA, MA – Alpha Tau Medical Ltd. (Nasdaq: DRTS / DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced the appointment of Maya Netser to its Board of Directors today.
“I am delighted to welcome Maya to the Board,” said CEO and Chairman, Uzi Sofer. “Maya brings a wealth of experience and a keen understanding of the industry from her many years of corporate leadership and advisory. She joins us as the Company is at an exciting strategic inflection point, undertaking a highly promising expansion into the treatment of internal organs. I am sure that Maya will be a wonderful partner in our mission to raise the standard of care for cancer patients worldwide.”
About Maya Netser
Maya Netser has over 25 years of experience as a C-level technology company leader, board member, investor, advisor, and law firm partner. She is the founder and Managing Partner of Quantum Leap VC, an early-stage fund focused on quantum technologies. Previously, Maya Netser served as CEO of Cabaret Biotech, an Israeli CAR-T immunotherapy company based on Professor Zelig Eshhar’s pioneering inventions in cancer immunotherapy. Under her leadership, Cabaret successfully commercialized its IP, culminating in a high-profile acquisition by Kite Pharma and Gilead Sciences.
She previously served as COO and board member of Voyager Labs, an AI-based technology company that enables organizations to extract granular actionable insights from unstructured data. She was responsible for corporate business development, finance, human resources, legal, and investor relations.
Maya Netser also has over 20 years of corporate and IP legal experience. From 2006-2015, she was a Partner at the law firm Herzog, Fox, and Neeman, where she established and led the firm’s technology practice, growing her team to 30 lawyers.
“I am so pleased to join Alpha Tau’s Board of Directors,” said Maya Netser. “I have been following the Company’s achievements with great interest and am eager to bring my life sciences and business development skills to help the Company continue to meet its extraordinary potential.”
Maya Netser holds an LL.B and an MBA from Tel Aviv University. She is also a member of the Israeli National Team of Directors.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
For more: https://www.alphatau.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.